Paolo Tarantino is a breast medical oncologist and clinical researcher. He’s obtained his medical degree at the University Federico II of Naples (Italy) and completed his medical oncology training at the European Institute of Oncology in Milan (Italy). In 2021 he joined the Breast Oncology Center of the Dana-Farber Cancer Institute, Harvard Medical School (Boston, MA). His research focuses on the tailoring of novel antibody-drug conjugates to treat breast cancer through innovative biomarkers.